RecallRadar

FDA Drug recall D-0512-2018

Nandrolone Decanoate USP for prescription compounding, packaged in a) 25g (NDC 58597-0081-4)

On 2018-02-28 the FDA classified a Class II recall of Nandrolone Decanoate USP for prescription compounding, packaged in a) 25g (NDC 58597-0081-4) by American Pharmaceutical Ingredients, citing CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0512-2018
ClassificationClass II
Statusterminated
Initiated2018-02-09
Published2018-02-28
Last updated2026-09-13 11:52 UTC
CompanyAmerican Pharmaceutical Ingredients
DistributionUS

Product

Nandrolone Decanoate USP for prescription compounding, packaged in a) 25g (NDC 58597-0081-4); b) 100g (NDC 58597-0081-6); c) 500g (NDC 58597-0081-7); d) 1000g (NDC 58597-0081-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Reason

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Identifiers

code_info
Lot #: a) 012716-1, 012716-2, Exp. 01/12/2019; 110316-3, Exp. 09/21/2021 b) 012716-1, 012716-3, Exp. 01/12/2019; 110…Lot #: a) 012716-1, 012716-2, Exp. 01/12/2019; 110316-3, Exp. 09/21/2021 b) 012716-1, 012716-3, Exp. 01/12/2019; 110316-1, 110316-3, Exp. 09/21/2021; c) 012716-1, 012716-3, Exp. 01/12/2019; 110316-1, 110316-2, Exp. 09/21/2021; exp. 09/21/2021; d) 012716-1, 012716-3, Exp. 01/12/2019; 041717-2, Exp. 04/06/2022; 110316-1, 110316-2, Exp. 09/21/2021.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0512-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.